Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Accounts Payables (2019 - 2025)

Outset Medical (OM) has disclosed Accounts Payables for 7 consecutive years, with $554000.0 as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 85.66% to $554000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $554000.0 through Dec 2025, down 85.66% year-over-year, with the annual reading at $554000.0 for FY2025, 85.66% down from the prior year.
  • Accounts Payables for Q4 2025 was $554000.0 at Outset Medical, down from $1.7 million in the prior quarter.
  • The five-year high for Accounts Payables was $6.8 million in Q1 2024, with the low at $554000.0 in Q4 2025.
  • Average Accounts Payables over 5 years is $3.1 million, with a median of $2.5 million recorded in 2021.
  • The sharpest move saw Accounts Payables skyrocketed 866.33% in 2023, then tumbled 85.66% in 2025.
  • Over 5 years, Accounts Payables stood at $1.8 million in 2021, then plummeted by 65.8% to $603000.0 in 2022, then surged by 866.33% to $5.8 million in 2023, then plummeted by 33.72% to $3.9 million in 2024, then crashed by 85.66% to $554000.0 in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $554000.0, $1.7 million, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.